Showing results (21-30 of 1,397) with videos related to
Sort By:
Pageof 140
Pharmacology Research & Perspectives|June 28, 2016
Characterization of death receptor 3-dependent aortic changes during inflammatory arthritisJessica O Williams, Eddie C Y Wang, Derek Lang, et al.Pharmacology Research & Perspectives|March 30, 2016
Pharmacologic immunosuppression of mononuclear phagocyte phagocytosis by caffeineRyan P Steck, Spencer L Hill, Evita G Weagel, et al.Pharmacology Research & Perspectives|March 30, 2016
Potential mechanism of enhanced postprandial glucagon-like peptide-1 release following treatment with a diacylglycerol acyltransferase 1 inhibitorJinqi Liu, David G McLaren, Dunlu Chen, et al.Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.Pharmacology Research & Perspectives|April 13, 2016
UGT concentrations in human rectal tissue after multidose, oral curcuminGary N Asher, John K Fallon, Philip C SmithPharmacology Research & Perspectives|April 13, 2016
Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybridMitali Chattopadhyay, Ravinder Kodela, Pascale L Duvalsaint, et al.Pharmacology Research & Perspectives|June 23, 2018
Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-O-sulfate in rats: Drug discrimination and physical dependenceJai Shankar K Yadlapalli, Shoban Babu Bommagani, Ryan D Mahelona, et al.Pharmacology Research & Perspectives|October 4, 2017
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinicallyGeorge K Dresser, Brad L Urquhart, Julianne Proniuk, et al.Pharmacology Research & Perspectives|October 4, 2017
Adverse drug reactions of montelukast in children and adultsMeindina G Haarman, Florence van Hunsel, Tjalling W de VriesPharmacology Research & Perspectives|October 4, 2017
Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover studyJutta Beier, Rainard Fuhr, Beatriz Seoane, et al.Pageof 140